Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 2,926–2,950 of 7,816 matching trials · page 118 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults NCT06733714 Transcranial Alternating Current Stimulation; Digital Cognitive Training Runs in: Brazil · 1 site |
NA other |
RECRUITING | 40 | Universidade Federal do Rio de Janeiro OTHER |
2024-12-13 |
|
Multicultural Healthy Diet to Reduce Cognitive Decline NCT03240406 Multicultural Healthy Diet; Usual Diet plus Self-Care Runs in: United States · 1 site |
NA other |
COMPLETED | 393 | Albert Einstein College of Medicine OTHER |
2024-12-12 |
|
Reducing Inappropriate Medication Use for BPSD NCT06040502 The DICE Approach Runs in: United States · 1 site |
NA other |
COMPLETED | 103 | University of California, Davis OTHER |
2024-12-12 |
|
Effects of a Computerised Cognitive Stimulation Versus Stimulating Leisure Activities NCT06058611 Cognitive stimulation; Stimulating leisure activities Runs in: Spain · 1 site |
NA other |
RECRUITING | 90 | Universidad de Zaragoza OTHER |
2024-12-12 |
|
Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects NCT06216054 LPM3770164 sustained release tablet; LPM3770164 sustained release t... Runs in: China · 1 site |
PHASE1 other |
COMPLETED | 40 | Luye Pharma Group Ltd. INDUSTRY |
2024-12-12 |
|
Effects of a Computerized Cognitive Stimulation Intervention Adapted to the Level of Cognitive Reserve NCT06279325 Computerized cognitive stimulation program; Face-to-face training-e... Runs in: Spain · 1 site |
NA other |
RECRUITING | 100 | Universidad de Zaragoza OTHER |
2024-12-12 |
|
Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality NCT06338215 Moderate Alcohol Drinking Pattern; Abstention Runs in: Spain · 1 site |
NA other |
RECRUITING | 10,000 | Clinica Universidad de Navarra, Universidad de Navarra OTHER |
2024-12-12 |
|
Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets NCT06474650 LPM3770164 sustained release tablet Runs in: China · 1 site |
PHASE1 other |
COMPLETED | 16 | Luye Pharma Group Ltd. INDUSTRY |
2024-12-12 |
|
Digital Health and Exercise for Autonomous Longevity Program NCT06722976 Multicomponent exercise programs Runs in: Portugal · 1 site |
NA other |
ENROLLING_BY_INVITATION | 120 | University of Beira Interior OTHER |
2024-12-12 |
|
Molecular PET Imaging and Plasma Biomarkers in Alzheimer´s Disease and Other Neurodegenerative Diseases NCT06731842 18F-RO948 Runs in: Sweden · 1 site |
NA other |
ENROLLING_BY_INVITATION | 100 | Karolinska Institutet OTHER |
2024-12-12 |
|
Tai Chi Versus Conventional Exercise to Improve Cognitive Performance in Older Adults With Mild Cognitive Impairment NCT05540613 Health Education; Conventional Exercise; Tai Chi Runs in: Hong Kong · 1 site |
NA other |
RECRUITING | 315 | The University of Hong Kong OTHER |
2024-12-11 |
|
COACH-Cog Intervention Adaptation Focus Groups NCT05775991 Runs in: United States · 1 site |
NA other |
COMPLETED | 18 | University of Rochester OTHER |
2024-12-11 |
|
Dementia Risk Prediction Model: Development and Validation NCT03943641 This is not an intervention study Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 400,000 | University of Edinburgh OTHER |
2024-12-10 |
|
We-PAP: A Couples-based Intervention for Sleep Apnea NCT04759157 Couples-based treatment; Standardized education Runs in: United States · 1 site |
NA other |
COMPLETED | 84 | University of Utah OTHER |
2024-12-10 |
|
Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008) NCT05602727 MK-1942; Placebo Runs in: Argentina; Australia; Canada; Colombia; Italy; Japan; New... · 74 sites |
PHASE2 other |
TERMINATED | 99 | Merck Sharp & Dohme LLC INDUSTRY |
2024-12-10 |
|
New Imaging Biomarkers Predictive of MA Progression NCT05939362 MRI follow-up Runs in: France · 1 site |
NA other |
RECRUITING | 80 | Poitiers University Hospital OTHER |
2024-12-10 |
|
Utilization of Exergame Programs Among Elderly Residents in Rural Nursing Care Centers NCT06717971 Exergame-based multicomponent training program.; Standard care Runs in: China · 1 site |
NA other |
COMPLETED | 232 | Aoyu Li OTHER |
2024-12-10 |
|
The Impact of Art Therapy on the Relationships Between Individuals Diagnosed With Alzheimer's Disease and Their Care Partners NCT06725251 Art Therapy Runs in: United States · 1 site |
NA other |
COMPLETED | 82 | Wake Forest University Health Sciences OTHER |
2024-12-10 |
|
Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial NCT02781220 Runs in: United States · 1 site |
NA other |
TERMINATED | 69 | University of Utah OTHER |
2024-12-09 |
|
Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy Subjects NCT04920786 TB006; Sterile saline (Placebo) Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 48 | TrueBinding, Inc. INDUSTRY |
2024-12-09 |
|
Enhancing Language Function in Aphasia NCT05443633 individualized speech-language training; standard language intervention Runs in: United States · 1 site |
NA other |
RECRUITING | 30 | University of Arizona OTHER |
2024-12-09 |
|
TB006 Expanded Access (EA) Compassionate Use NCT05959239 TB006 |
NA other |
AVAILABLE | — | TrueBinding, Inc. INDUSTRY |
2024-12-09 |
|
Design of Personalised SupplemenTs Based on the Gut MicRobiota Through Artificial Intelligence for Alzheimer's Patients NCT06199193 Personalized diet; Dietary counseling Runs in: Spain · 2 sites |
NA other |
UNKNOWN | 120 | Universidad Complutense de Madrid OTHER |
2024-12-09 |
|
Acceptance Commitment Therapy for Caregivers of People with Memory Loss NCT05749939 Acceptance and Commitment Therapy Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | 121 | Utah State University OTHER |
2024-12-06 |
|
Extracellular Vesicles for HD NCT06082713 Runs in: United States · 1 site |
NA other |
RECRUITING | 100 | University of Central Florida OTHER |
2024-12-06 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial